| Logo | Name | Σ | ||
|---|---|---|---|---|
 | Greater Paris University Hospitals - AP-HP Nous soignons et innovons 365 jours par an. AP-HP (Greater Paris University Hospitals) is a European world-renowned university hospital. Its 39 hospitals treat 8 million people every year: in consultation, emergency, during scheduled or home hospitalizations. The AP-HP provides a public health service for everyone, 24 hours a day. This mission is a duty as well as a great source of pride. AP-HP is the leading employer in the Greater Paris area: 100.000 staff members – doctors, researchers, paramedical staff, administrative personnel and workers – work there. Toutes les spécialités médicales de la néonatologie à la gériatrie en passant par … Sectors: | 1602 | 1147 | 108 |
 | Ipsos France [Automatic translation follows] You act better when you are sure At Ipsos, we are passionately curious about people, markets, brands and society. We help our customers navigate a rapidly changing world faster and more easily. We provide them with the inspiration they need to make strategic decisions. We provide them with security, speed, simplicity and substance. We are GAME CHANGERS. Marketing Studies, Market Research, Advertising, Media, content and new technologies, Opinion, Customer relations and satisfaction, CRM, Manager and employee engagement, Omnibus, Access Panels, Large Surveys, Quality Studies, and Product and service innovation Sectors: | 1680 | 1189 | 402 |
 | BFM Business [Automatic translation follows] First economic and financial information channel in France. BFM Business TV is the leading economic and financial news channel in France. It is distinguished by programming centered on the search for expertise. Programs on economic news have established themselves as economic news events. “Good Morning Business” for example, offers on its guest set the latest innovations, editorials and information on underlying trends. BFM Business TV is also available live on our website as well as on an application dedicated to it. Tech, Stock Market, Economy, Real Estate, Business, Automobile, and High-Tech Sectors: | 4112 | 3598 | 504 |
 | Métropole Européenne de Lille (MEL) [Automatic translation follows] Public Establishment for Intercommunal Cooperation (EPCI) serving 95 municipalities for more than a million inhabitants. The European Metropolis of Lille, a public establishment for intermunicipal cooperation, brings together more than a million inhabitants and 95 municipalities. Its territory is both rural and urban, made up of large towns and villages. It exercises its skills in 19 essential areas serving users such as planning, roads, sanitation, transport, culture, tourism, housing, economic development, etc. MEL services include more than 2,800 agents and more than 100 professions. Supported by an ambitious continuing training policy, they open up attractive professional development … Sectors: | 1145 | 893 | 207 |
 | Carrefour The Carrefour Group: one of the world’s leading retailers In 50 years, the Carrefour Group has become a world leader in the retail sector. The second largest retailer in the world and the largest in Europe, the Group now features four major grocery retail formats: hypermarkets, supermarkets, cash & carry and convenience stores. The Carrefour Group currently has over 9 900 company-owned and franchise stores. An international retailer A pioneer in countries such as Brazil in 1975 and China in 1995, the Group now operates on three major markets: Europe, Latin America and Asia. With a presence in more than … Tags: CAC40 Sectors: | 2364 | 1939 | 170 |
 | Relais Colis Inventeur du concept de livraison en relais de proximité dès 1983, Relais Colis est le 1er réseau de livraison aux particuliers alliant livraison en points de proximité et livraison à domicile pour livrer tous les formats de colis. Riche de 50 ans d’expérience, Relais Colis est aujourd’hui le partenaire de nombreux acteurs e-commerce de premier plan, séduits par ses importants investissements dans ses outils de traçabilité et le pilotage de son réseau. Relais Colis, c’est 45 millions de colis livrés par an en relais, 2 millions à domicile, un réseau intégré de 4 hubs nationaux, 25 agences régionales, 5.200 commerçants … Sectors: | 41 | 29 | 14 |
 | Institut Analgesia [Automatic translation follows] 1st pain research foundation in France A major public health problem, chronic pain today affects 1 in 5 adults, or more than 12 million French people. And as the therapeutic arsenal is both aging and insufficient, nearly 2 thirds of patients believe that their pain is insufficiently controlled. Pain also has a very significant impact on health at work. Back pain is the leading cause of disability in the world and musculoskeletal disorders represent the leading cause of occupational illness in France. Pain alone impacts 88 million working days per year in France. Fighting pain is therefore … Sectors: | 126 | 33 | 95 |
 | Fondation Adolphe de Rothschild Head and Neck Expertise. Created in 1905 in the 19th district of Paris, the Adolphe de Rothschild Foundation Hospital is a private health institution of collective interest (ESPIC) specialized in all pathologies of the head and neck for adults and children. This university hospital offers excellent care at a conventional rate (non-profit) and treats nearly 300,000 patients every year. Providing the continuum of care, research and training, the Rothschild Foundation Hospital pilots 125 clinical research studies each year, publishes nearly 300 scientific articles and trains nearly 700 students. The services of the Rothschild Foundation Hospital regularly appear at the top … Sectors: | 169 | 71 | 95 |
 | Gustave Roussy [Automatic translation follows] Prevention / Care / Research / Teaching, serving patients with #cancer. Gustave Roussy, the leading cancer center in Europe, 4th best cancer hospital in the world, constitutes a global center of expertise against cancer, serving patients. It brings together 3,100 professionals whose missions are prevention, care, research and education on two sites: in Villejuif and Chevilly-Larue (Grand Paris). A private establishment of collective interest, Gustave Roussy is authorized to receive donations and legacies. Cancerology, care, research, and teaching Sectors: | 320 | 254 | 62 |
 | Pierre Fabre Group New ways to care Pierre Fabre Group held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : 💊 A pharmaceutical group with a strong positioning : medical and natural 🥈 The second largest dermo-cosmetics laboratory in the world 🥈 The second largest private French pharmaceutical group 🥇 The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale … Sectors: | 397 | 289 | 90 |
 | Allianz X Investing in the future Allianz X invests in digital frontrunners in ecosystems relevant to insurance and asset management. In just a few years, it has grown to a portfolio of more than 25 companies and AuM of over 1.5 billion euros. Allianz X has counted 12 unicorns among its portfolio so far. The heart and brains behind it all are a talented team of around 40 people. As one of the pillars of the Allianz Group’s digital transformation strategy, Allianz X provides an interface between Allianz Operating Entities and the broader digital ecosystem, enabling collaborative partnerships in insurtech, fintech, and … | 3129 | 1797 | 670 |
 | Leem [Automatic translation follows] The professional organization of pharmaceutical companies operating in France. Leem, Pharmaceutical Companies, brings together companies in the pharmaceutical industry sector in France. Created more than 130 years ago, Leem today has nearly 270 member companies, which generate nearly 98% of the total pharmaceutical turnover in France. The pharmaceutical industry employs 100,000 people in more than 150 professions, and has recruited 10,000 employees per year for 10 years. Each year, the pharmaceutical industry invests 12% of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its R&D centers, … Sectors: | 534 | 294 | 201 |
 | IncubAlliance Incubateur des start-up tech et deeptech du cluster Paris-Saclay Accompagnement de projets de création d'entreprises technologiques innovants Entrepreneurship, Consulting, Technology, Public R&D, Innovation, and Investment | 132 | 39 | 107 |
 | Bristol Myers Squibb At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, … Sectors: | 331 | 299 | 13 |
 | Umanis [Automatic translation follows] Founded in 1990, Umanis is a consulting and engineering company specializing in Business Intelligence for nearly 70% of its activity, Customer Relationship Management and Web/IT. Umanis supports its clients on all of their IT projects (consulting, development, integration, third-party application maintenance, outsourcing and training) according to several modes of intervention: on-site service, fixed price, in shared service center and in SaaS mode . More than 70% of CAC 40 companies trust us, year after year. In 2013, Umanis took a majority stake in Hélice, bringing the workforce of the group thus formed to 1,600 employees. The group … Sectors: | 138 | 44 | 61 |
 | KLESIA [Automatic translation follows] General interest insurer KLESIA is a social protection group. Our main businesses: supplementary health insurance, mutual insurance, supplementary retirement and insurance. A joint non-profit group, we have no shareholders to pay. KLESIA is made up of entities represented by employers and employees who guide the Group's strategy and make decisions to best defend the interests of customers. Joining us means participating in large-scale projects of general interest serving 300,000 companies, 4.7 million people covered by personal insurance and 2.1 million retirees. KLESIA affirms every day its desire to be a socially responsible General Interest insurer within a … Sectors: | 518 | 296 | 190 |
 | Hôpital NOVO (Nord-Ouest Val-d'Oise) [Automatic translation follows] NOVO Hospital: to reinvent the local hospital and imagine tomorrow. NOVO Hospital (North-West Val-d'Oise) is a new establishment born on January 1, 2023, from the merger of 3 establishments: the René-Dubos Hospital Center of Pontoise (CHRD), the Carnelle Portes Hospital Group of 'Oise (GHCPO) and the Vexin Intercommunal Hospital Group (GHIV). The NOVO Hospital is based on a shared medical project, regional hubs, transversal medical teams, identified care sectors, transversal administrative departments and unified healthcare authorities. A key player in the public hospital service in Ile-de-France, its objective is to contribute to combating social and geographical inequalities … Sectors: | 66 | 19 | 50 |
 | Orange Services Your partner for IT and business solutions Orange Services was created in 2013 and is a 100% owned subsidiary of Orange Group. As a technology services company, our DNA is in IT, but our teams also work in other domains including mobile networks and a number of commercial and business functions. Orange Services is one of the largest technology hubs in the Orange Group, working internationally for both Orange corporate functions and country operations. Through a unique combination of cutting edge know-how and expertise, our teams provide a broad range of services: development and supervision of IT services (in domains … Sectors: | 302 | 116 | 126 |
 | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: | 2018 | 1471 | 463 |
 | Bordeaux Métropole 1 métropole au service de ses 28 communes et de ses 815 000 habitants. Bordeaux Métropole (formerly the Urban Community of Bordeaux), is the intercommunal structure gathering the city of Bordeaux (France) and some of its suburbs. Sectors: | 870 | 766 | 90 |
 | Gilead Sciences Creating Possible At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines Sectors: | 481 | 379 | 42 |
 | Takeda Better Health, Brighter Future We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Pharmaceuticals, Therapeutics, … Sectors: | 418 | 260 | 137 |
 | Servier Pharmaceuticals We are dedicated to therapeutic progress to serve patient needs. Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and … Sectors: | 353 | 196 | 54 |
 | Pfizer We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday. Follow our progress as we accelerate the next generation of cancer treatments at LetsOutdoCancer.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them. Sectors: | 947 | 757 | 83 |
 | Novartis Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy Sectors: | 587 | 494 | 52 |
 | Microsoft Every company has a mission. What's ours? To empower every person and every organization to achieve more. We believe technology can and should be a force for good and that meaningful innovation contributes to a brighter world in the future and today. Our culture doesn’t just encourage curiosity; it embraces it. Each day we make progress together by showing up as our authentic selves. We show up with a learn-it-all mentality. We show up cheering on others, knowing their success doesn't diminish our own. We show up every day open to learning our own biases, changing our behavior, and inviting … Sectors: | 7594 | 6137 | 986 |
 | Incyte Incyte is a global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines. We are committed to the relentless pursuit of science that can improve the lives of patients. Our unique expertise in medicinal chemistry and biology has enabled us to create a diversified portfolio of marketed products and clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing pipeline of medicines across Oncology and Inflammation & AutoImmunity. Headquartered in Wilmington, Delaware, Incyte has more than 1,700 employees and operations in North America, … Sectors: | 75 | 50 | 18 |
 | Aviva Investors Bringing it all together for today's investor Welcome to Aviva Investors. The global asset manager that chooses integration. The future is full of questions. Only by working closely with our clients can we find the answers. That’s why we integrate our whole business around our clients – their goals, their values and the experience they have when they work with us. That’s why we start by listening closely and understanding their investment aspirations and concerns – from low prospective investment returns, to highly correlated asset prices; from the prospect of rising global interest rates, to the challenges and opportunities of … Sectors: | 1276 | 724 | 189 |
 | AstraZeneca What science can do We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business Sectors: | 2269 | 1645 | 119 |
 | Amgen #WeareBiotech Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world … Sectors: | 972 | 570 | 196 |
 | AbbVie AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html. Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care Sectors: | 336 | 249 | 66 |
 | MSD We aspire to be the premier research-intensive biopharmaceutical company. At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of … Sectors: | 1245 | 1061 | 113 |
 | Johnson & Johnson At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals Sectors: | 2552 | 1652 | 317 |
 | Groupe TF1 [Automatic translation follows] Welcome to a world of content The TF1 group is a global player in the production, editing and distribution of content. Through its content, its ambition is to inspire society positively. The TF1 group organizes its activities in several additional poles: • The Broadcast pole with 5 clear channels (TF1, TMC, TFX, TF1 Films series, LCI), 4 thematic channels (Ushuaia TV, TV history, Breizh TV, Club series), 2 content platforms on demand (MyTF1, Tfou max), and the TF1 advertising. • The production center with Newen, which brings together 9 studios in France and internationally. • The digital … Sectors: | 3717 | 3035 | 171 |
Health